Memorandum by the British Lung Foundation
(HI 50)
HEALTH INEQUALITIES
INTRODUCTION
1. Together with cancer and circulatory
diseases, respiratory disease is one of the three greatest diseases
of inequality in the UK. This submission from the British Lung
Foundation focuses on the extent to which the NHS can help to
achieve a reduction in health inequalities associated with respiratory
disease, through primary and public health services.
EXECUTIVE SUMMARY
2. Respiratory disease is the UK's second
biggest killer[1]
and the most common cause of emergency hospital admissions[2].
Almost half of all respiratory disease deaths (44%) in the UK
are associated with social class inequalities.[3]
3. Incidence and mortality rates from respiratory
disease are higher in deprived populations due to: low birth weights;
childhood chest illnesses; damp housing conditions; poor diet;
smoking; and dusty occupations such as mining and milling.
4. Respiratory diseases associated with
social class inequalities include lung cancer, COPD (Chronic Obstructive
Pulmonary Disease), asthma, TB and childhood respiratory illnesses.
5. Deprived populations have the highest
prevalence and highest under-diagnosis of COPD, a progressive
lung disease caused mainly by smoking.[4]
6. The prevalence of smoking has declined
greatly over thirty years but has remained over 60% in the poorest
groups, despite changes in policy and social climate.[5]
Current evidence suggests that smoking cessation services are
not reaching all sectors of society.[6]
7. A general lack of public awareness of
COPD means that there are an estimated 2.8 million people in the
UK who don't know they have the disease. If left untreated, it
could severely restrict their lives and eventually kill them.[7]
8. Misdiagnosis of COPD is a common theme
in the UK, as are repeated admissions to hospital and poor outcomes
of care. On average 15% of those admitted to hospital die within
three months.[8]
9. Action on diagnosis, treatment and care
of COPD would make a great difference to the delivery of the PSA
target on health inequalities.
10. Research by the British Lung Foundation
identifies communities at highest risk of future COPD hospital
admission at postcode level and facilitates the precise targeting
of at risk groups with social marketing campaigns. Many of these
communities are in Spearhead areas.[9]
11. The BLF recommends the actions on pages
4-6 below. They include the following:
12. Existing QOF points in relation to spirometry
testing should be linked to levels of spirometry training, ensuring
that QOF points are attributed to GP practices who guarantee that
testing is carried out by appropriately trained individuals.
13. Existing registers of people with COPD
in primary care should be developed to include stages of disease
progression, current treatment plans and whether end of life care
is needed. Existing QOF points in relation to the register should
be amended to reflect this change.
14. Smoking cessation services and nicotine
replacement therapy should be made available for as long as is
needed and delivered in a non-judgmental manner.
15. Each PCT should ensure that one of the
6 awareness campaigns it is obliged to carry out every year should
be a respiratory disease campaign. Targeted awareness and diagnosis
campaigns should be undertaken, particularly in the most deprived
communities in the UK, to find people with undiagnosed COPD and
ensure they receive appropriate treatment and care.
16. A written information pack should be
given to all those diagnosed with COPD. New QOF points should
be introduced for delivery of such information.
17. The tariffs for Acute Care should be
unbundled so that community care for people with COPD can be funded
and unnecessary hospital admission avoided.
18. PCOs should identify those at risk of
COPD in the community and introduce services aimed at preventing
unnecessary hospital admissions (outlined below).
BACKGROUND
19. Respiratory disease is the second biggest
killer in the UK, accounting for 117,456 deaths a year. It is
the most common cause of emergency hospital admissions and costs
the NHS and society as a whole £6.6 billion a year.[10]
20. Almost half of all respiratory disease
deaths (44%) in the UK are associated with social class inequalities
compared with 28% of deaths from ischaemic heart disease.[11]
21. Respiratory diseases associated with
social class inequalities include lung cancer, COPD, asthma, TB
and childhood respiratory illnesses. The issue of lung cancer
is being addressed by the Department of Health under the Cancer
Plan and the Cancer Reform Strategy.
22. COPD (Chronic Obstructive Pulmonary
Disease) is a progressive lung disease caused mainly by smoking.
Deprived populations have the highest prevalence and highest under-diagnosis
of COPD.[12]
23. COPD "hotspots" are concentrated
in Scotland, ex-industrial and inner city areas of Northern England,
and pockets of deprivation in otherwise affluent areas. Many of
these hotspots have been identified as Spearhead areas.[13]
24. In women, respiratory disease accounts
for 21% of the life expectancy gap between Spearhead areas and
the rest of Englandonly circulatory diseases account for
more (30%). COPD accounts for more than half of the respiratory
total.[14]
25. In men, respiratory disease accounts
for 15% of the life expectancy gap between Spearhead areas and
the rest of Englandonly circulatory diseases and cancers
account for more. COPD accounts for more than half of the respiratory
total.[15]
ISSUES CONCERNING
HEALTH INEQUALITIES
ASSOCIATED WITH
RESPIRATORY DISEASE.
26. Social class and poverty have an important
effect on determining who has respiratory disease and who dies
from it.
27. Incidence and mortality rates from respiratory
disease are higher in poorer social groups due to:
(a) Antenatal and early life experiences:
low birth weights; childhood chest illnesses; poor housing where
families are exposed to damp and mould; poor diet; obesity; exposure
to second hand smoke
(b) Occupationrespiratory diseases
such as COPD are high amongst occupations such as coalmining and
other dusty jobs. The UK is about to experience an epidemic of
the chest cancer mesothelioma, which occurs amongst those exposed
to asbestos in the workplace.
(c) Smokingjust under half of respiratory
diseases are caused by smoking. The prevalence of smoking has
declined greatly over thirty years but has remained over 60% in
the poorest groups, despite changes in policy and social climate.
Poorer smokers are much less likely to have quit and take in substantially
more nicotine from their smoking and are more dependent.
28. At present about 24% of adults, or 10
million people, are smokers. At current reduction rates, it will
take around 20 years to reduce this figure to 5 million. Half
of this number will die prematurely from smoking, and social inequalities
in mortality are likely to become more pronounced. Current evidence
suggests that smoking cessation services are not reaching all
sectors of society.
29. Communities in greatest need are least
likely to receive the health services that they require. The diagnosis
and treatment of lung disease has been neglected by local and
national health care services in the UK, partly because of its
association with smoking and partly through a lack of awareness
amongst the public and health care professionals, particularly
in primary care, of diseases like COPD.[16]
30. Misdiagnosis of COPD is a common theme,
as is repeated admission to hospital and poor outcomes of care.
On average 15% of those admitted to hospital die within three
months.[17]
31. A general lack of public awareness of
COPD in particular means that there are an estimated 2.8 million
people[18]
with the condition who don't know they have a disease which, if
left untreated, could severely restrict their lives and eventually
kill them. Most people are currently diagnosed when the disease
is in its later stages when symptoms are severe and extensive
lung damage is not reversible.[19]
32. Research by the British Lung Foundation
carried out by Dr Foster Intelligence shows that most of the "missing
millions" of people with COPD are likely to be found in the
most deprived communities in the UK. The research predicted COPD
future hospital admissions in every PCO in the UK using various
data sources including hospital admissions data; GP surgery registrations
data; Experian's Mosaic lifestyle segmentation and TGI Target
Group Index Analysis. The research identifies communities at highest
risk of COPD hospital admission at postcode level and facilitates
the precise targeting of at risk groups with social marketing
campaigns.[20]
33. Equity of provision is likely to widen
health inequalities from COPD.
34. The government is unlikely to meet its
PSA target in respect of health inequalities unless it addresses
the above points. Action on the diagnosis, treatment and care
of COPD would make a great difference to the delivery of this
target.
35. BLF specialist respiratory nurses in
Glasgow have made significant progress in providing treatment
and care in the community of people with COPD, improving their
quality of life and in reducing unnecessary hospital admissions.
THE BLF RECOMMENDS
THE FOLLOWING
COURSES OF
ACTION FOR
THE NHS TO
REDUCE HEALTH
INEQUALITIES IN
RELATION TO
RESPIRATORY DISEASE:
36. Ensure health professionals, particularly
in primary care, receive better education and training in the
causes and symptoms of respiratory disease.
37. Ensure health professionals in primary
care have the skills and equipment to carry out regular and efficient
spirometry testing (a simple lung test) on every individual from
the age of 7 onwards, to be repeated every ten years or more often
for those at increased risk of respiratory disease.
38. Care should be provided according to
need, with the aim of achieving equity of outcome across different
groups and areas.
39. Existing QOF points in relation to spirometry
testing should be linked to levels of spirometry training, ensuring
that QOFs are only paid to GP practices which can prove that testing
is carried out by appropriately trained individuals.
40. Existing registers of people with COPD
in primary care should be developed to include stages of disease
progression, current treatment plans and whether end of life care
is needed. Existing QOF points in relation to the register should
be amended to reflect this change.
41. Smoking cessation services should be
improved by extending the follow up time to one year and by making
nicotine replacement therapy available for as long as it is needed.
42. Each PCT should ensure that one of the
6 awareness campaigns it is obliged to carry out every year should
be a respiratory disease campaign. Targeted awareness and diagnosis
campaigns should be undertaken, particularly in the most deprived
communities in the UK, to find people with undiagnosed COPD and
ensure they receive appropriate treatment and care.
43. An information pack should be given
to all those diagnosed with COPD. The pack should be given on
diagnosis and should be relevant to the stage of the disease.
It should contain high quality information in a format and at
a level of complexity appropriate to their needs and be culturally
appropriate. It should include information about treatments such
as Non-invasive ventilation.
44. New QOF points should be introduced
for the production and delivery of such information.
45. Everyone with COPD should be given a
self-management plan. This, together with the information above,
should help people to manage their own condition better and to
enable them to stay out of hospital, reducing the burden and cost
of emergency admissions.
46. Written Care Plans should be introduced
for everyone with COPD, including self-management plans for each
patient.
47. Managed Clinical Networks for COPD should
be established.
48. Non-invasive ventilation should be available
for people with COPD who want it and are admitted to hospital.
49. People with COPD tell us they prefer
to be treated at home. At present most payments contribute to
keeping people with COPD in hospital. The tariffs for Acute Care
should be unbundled so that community care for people with COPD
can be funded.
50. Early supportive discharge should be
available to everyone admitted to hospital with COPD and best
practice followed on the provision of support at home.
51. PCOs should identify those at risk of
COPD in the community and introduce services aimed at preventing
unnecessary hospital admissions. These services could include:
52. Specialist help, advice and interventions
should be available 24 hours a day for people with COPD who experience
acute breathing problems. Patients prefer to receive this advice
by telephone; a 24/7 Helpline and Advice service should be introduced
to prevent unnecessary hospital admissions and help medication
management.
53. Community nurses skilled in the care
of people with COPD should be increased, particularly in areas
of greatest need, following the good practice examples set by
BLF nurses in certain areas of the UK.
54. Pulmonary rehabilitation should be provided
for everyone with COPD who needs it according to existing NICE
guidance, and follow up exercise classes should be provided for
everyone who could benefit from it throughout the UK.
55. Patients and carers affected by COPD
should be notified when they have reached the stage where end
of life care is needed. A different package of care should be
identified of a standard equivalent to that currently received
by people affected by cancer.
56. The forthcoming NSF in COPD should be
funded and taken forward in a positive manner.
57. A Health Equity Audit should be undertaken
with regard to COPD incidence, prevalence and mortality.
58. Managed Clinical Networks for COPD in
Scotland are an important first step but they must operate to
the standard set by the forthcoming NSF for COPD as the incidence
in Scotland is extremely high.
59. Respiratory strategies have been introduced
in Wales and Northern Ireland but no action has been taken to
implement them. These strategies must follow the examples set
by England and Scotland in improving diagnosis, treatment and
care for people with COPD.
ABOUT THE
BLF
60. The British Lung Foundation (BLF) is
the only charity working to help the eight million people in the
UK with all lung conditions.
61. The BLF runs a network of support groups
across the country for people living with lung disease. There
are more than 200 Breathe Easy Groups across the UK, all run by
patients to support patients.
62. The BLF provides a wide range of information
on more than 40 lung conditions, in the form of leaflets and fact
sheets, all of which can be accessed via our website (www.lunguk.org).
63. The BLF also funds medical research
into all forms of lung diseases.
January 2008
1 Burden of Lung Disease, British Thoracic Society
2006. Back
2
Ibid. Back
3
Ibid. Back
4
Association of Public Health Observatories. Back
5
GHS 1973 and 2004. Back
6
Northwest Public Health Observatory. Back
7
Shahab L, Jarvis MJ, Britton J, and West R, Prevalence, diagnosis
and relation to tobacco dependence of chronic obstructive pulmonary
disease in a nationally representative population sample. Back
8
Commission for Healthcare Audit and Inspection, Clearing the
Air: A national study of chronic obstructive pulmonary disease,
2006. Back
9
Invisible Lives: Chronic Obstructive Pulmonary Disease (COPD)-finding
the missing millions. British Lung Foundation, 2007. Back
10
Burden of Lung Disease, British Thoracic Society 2006. Back
11
Ibid. Back
12
Association of Public Health Observatories. Back
13
Invisible Lives: Chronic Obstructive Pulmonary Disease (COPD)-finding
the missing millions. British Lung Foundation, 2007. Back
14
Association of Public Health Observatories. Back
15
Ibid. Back
16
Commission for Healthcare Audit and Inspection, Clearing the
Air: A national study of chronic obstructive pulmonary disease,
2006. Back
17
Ibid. Back
18
Shahab L, Jarvis MJ, Britton J, and West R, Prevalence, diagnosis
and relation to tobacco dependence of chronic obstructive pulmonary
disease in a nationally representative population sample. Back
19
Invisible Lives: Chronic Obstructive Pulmonary Disease (COPD)-finding
the missing millions. British Lung Foundation, 2007. Back
20
Ibid. Back
|